Semaglutide for Obesity & Weight Loss
How It Works
GLP-1 receptor agonist that reduces appetite and improves glucose metabolism.
Research Evidence
STEP trials show 15-20% body weight loss. Wegovy FDA approved for chronic weight management.
Dosing Protocol
Start 0.25mg weekly, increase by 0.25mg monthly to 2.4mg weekly maintenance.
Important Considerations
- !Requires prescription
- !Significant GI side effects
- !Muscle loss risk without exercise
- !May need lifelong use
Frequently Asked Questions
Does Semaglutide work for obesity & weight loss?
STEP trials show 15-20% body weight loss. Wegovy FDA approved for chronic weight management. Research level: FDA approved, extensive clinical data.
How does Semaglutide help with obesity & weight loss?
GLP-1 receptor agonist that reduces appetite and improves glucose metabolism.
What is the Semaglutide dosage for obesity & weight loss?
Start 0.25mg weekly, increase by 0.25mg monthly to 2.4mg weekly maintenance.
Is Semaglutide safe for obesity & weight loss?
Key considerations: Requires prescription. Significant GI side effects. Muscle loss risk without exercise. May need lifelong use. Always consult a healthcare provider.
How long until Semaglutide works for obesity & weight loss?
Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.